The European Commission has approved Astellas’ Xospata (gilteritinib) for patients with relapsed or refractory FLT3-positive acute myeloid leukemia (AML), cementing its lead over a rival drug ...
Pfizer's BENEGENE-2 study met its primary endpoint of non-inferiority and superiority ... CSL’s gene therapy for haemophilia B was recommended for approval by the EMA’s human medicine ...
Resistance to menin inhibitors often occurs in the initially sensitive MLL-rearranged (MLLr) leukemias. Here authors discover that inhibition of guanine nucleotide biosynthesis leads to myeloid ...
Stop cyberattacks such as ransomware and move at machine speed with industry-transforming AI that amplifies your security team’s strengths. Help protect your multiplatform and IoT devices with a ...
Simplify IT workstreams and empower employees to be more productive without compromising security. Unify mission-critical advanced endpoint management and security solutions with the Intune Suite. All ...
After hours: March 21 at 6:20:36 PM EDT Loading Chart for DTIL ...
Add a description, image, and links to the microsoft-endpoint-manager topic page so that developers can more easily learn about it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback